Navigation Links
Cancer Research Institute invests $450k in Oncovir to manufacture powerful immune stimulant
Date:1/21/2011

NEW YORK, NY, Jan. 21, 2011 Cancer Research Institute, Inc. (CRI), a U.S. nonprofit organization founded in 1953 to advance the science of tumor immunology and foster the discovery and development of new cancer immunotherapies, announced today that its Cancer Vaccine Acceleration Fund (CVAF), a joint initiative with the Ludwig Institute for Cancer Research (LICR), has completed a new investment agreement with Oncovir, Inc., a biotechnology company based in Washington, D.C., to enable the production of the immunological stimulant Hiltonol (Poly-ICLC).

"CVAF support is a critical factor enabling the manufacture of enough high-grade Hiltonol for clinical testing not only in cancer vaccines, but also for many other diseases for which it holds promise," says Andres M. Salazar, M.D., founder, chief executive officer, and scientific director of Oncovir.

Through the collaboration, CVAF will provide $450,000 to Oncovir to help fund the manufacture of clinical grade Hiltonol. As part of the agreement, 10,000 vials of Hiltonol will be dedicated exclusively for use in 10 to 15 early- and mid-phase clinical trials designed and conducted within the CRI/LICR Cancer Vaccine Collaborative (CVC), a coordinated global network of 19 academic clinical trial sites and advanced immunological monitoring laboratories. Since it was established in 2001, the CVC has completed more than 22 early-phase clinical trials of different, multi-component cancer vaccine formulations, with an additional 21 trials currently ongoing and 4 more planned to begin patient accrual.

Members of the CVC's Coordinating and Review Committee have identified Hiltonol as a powerful immunomodulator with the potential to enhance the efficacy of therapeutic cancer vaccines. In addition to holding a dedicated supply of Hiltonol, CVAF will also receive a perpetual non-exclusive license for the agent's use in combination with therapeutic cancer vaccines, according to the terms of the agr
'/>"/>

Contact: Brian M. Brewer
bbrewer@cancerresearch.org
212-688-7515
Cancer Research Institute
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Go figure: Math model may help researchers with stem cell, cancer therapies
2. Uncovering the genetics of prostate cancer
3. Roundworm unlocks pancreatic cancer pathway
4. Researchers unlock how progesterone increases breast cancer risk
5. MicroRNA suppresses prostate cancer stem cells and metastasis
6. Researchers learn why PSA levels reflect prostate cancer progression
7. TGen and Genomic Health Inc. discover genes affecting cancer drug
8. Measles virus, a weapon against cancer?
9. Study identifies new genetic signatures of breast cancer drug resistance
10. An earlier start on diagnosing breast, prostate cancers
11. Early investigations promising for detecting metastatic breast cancer cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/8/2015)... Calif. , May 8, 2015 Synaptics Inc. ... solutions, today announced that members of the executive management team ... Morgan 43rd Annual Technology, Media and Telecom Conference Date: ... Hotel in Boston, MA ... 27, 2015 Time: 2:45pm ET Location: The New York Palace ...
(Date:4/27/2015)... , Apr. 27, 2015 NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... shipping to pre-order customers the first week of May, ... the month of May. Gino ... significant milestone for the company as Wocket® enters the ...
(Date:4/17/2015)... , April 17, 2015 ... security concerns, and technological advancement to drive biometric ... until 2020   According to ... Arabia Biometric Systems Market Forecast &  Opportunities, 2020 ", biometric systems market ... projected to register growth at CAGR of over ...
Breaking Biology News(10 mins):Synaptics to Present at Upcoming Investor Conferences 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3
... one part water. Swirl your fingers in it slowly and the ... fist and you meet a rubbery solid -- so solid you ... It turns out that cell membranes or, more precisely the ... membranes -- behave the same way, say University of Oregon scientists. ...
... Federation of American Societies for Experimental Biology (FASEB) Minority ... travel award recipients for the 2010 American Society of ... November 2-6, 2010. These awards are meant to ... scientists into the mainstream of the basic science community ...
... NY - A study at the U.S. Department of Energy,s ... with a radioactive form of carbon can be used to ... in the human brain. The research, published in the November ... of the brain where aromatase is concentrated may be unique ...
Cached Biology News:Cell membranes behave like cornstarch and water 2PET scans reveal estrogen-producing hotspots in human brain 2
(Date:6/3/2015)... 2015 The International Myeloma Foundation (IMF) – ... working toward prevention and a cure – will host ... (IMWG) Summit June 8-10 in Vienna, Austria ... the 2015 Summit, which convenes on the eve of ... The focus of the IMWG is on incorporating recent ...
(Date:6/3/2015)... Pismo Beach, CA (PRWEB) June 03, 2015 ... passed a Senate Energy, Utilities and Communications Committee (11-0) and ... the DA CAP) and renewable energy. , The Committee Chairman ... amended to increase the CAP by 8,000 GWh and would ... the utility wait list. , This “Wait List” and ...
(Date:6/3/2015)... England and CHICAGO , ... plc ("Circassia" or "the Company"; LSE: CIR), a specialty ... and non-clinical data relating to the Company,s novel immunotherapy ... will be presented at the 2015 European Academy of ... Barcelona, Spain on 6-10 June. ...
(Date:6/3/2015)... Innovative biomass supply chain industry leader, Genera ... the first annual Advanced Bioeconomy Feedstocks Conference ... New Orleans, June 9-10, the conference brings together leaders ... the advancements of feedstock by discussing pressing issues such ... improvement and more. , As a tier-one ...
Breaking Biology Technology:International Myeloma Foundation Brings Together 100 of the World's Top Myeloma Experts June 8-10 in Vienna, Austria for 6th Annual Summit 2International Myeloma Foundation Brings Together 100 of the World's Top Myeloma Experts June 8-10 in Vienna, Austria for 6th Annual Summit 3International Myeloma Foundation Brings Together 100 of the World's Top Myeloma Experts June 8-10 in Vienna, Austria for 6th Annual Summit 4Bmark Energy Announces the Sign-up Deadline for Companies Interested in California’s Direct Access Program is June 12th, 2015 at 5:00pm. 2Circassia to Present at EAACI Annual Meeting, Barcelona, Spain, 6-10 June 2015 2Circassia to Present at EAACI Annual Meeting, Barcelona, Spain, 6-10 June 2015 3Genera to Sponsor Advanced Bioeconomy Feedstocks Conference 2015 2Genera to Sponsor Advanced Bioeconomy Feedstocks Conference 2015 3
... Candidate -, PRINCETON, N.J., April 10, 2008 ... protein production,company, today announced that it has entered ... LLC. According to the,agreement, Laureate will produce Alopexx,s ... planned for use in clinical trials, and later,for ...
... million, up 13 percent over ... -, CAMBRIDGE, Mass., April 10 Millennium,Pharmaceuticals, Inc. ... sales of $83.5 million for its flagship product VELCADE, ... relapsed multiple,myeloma. These results represent a 13 percent increase ...
... EVANSTON, Ill. --- Carbon nanotubes are promising materials ... mechanical, thermal, chemical, optical and electrical properties. , ... nanotubes to make thin films that are semitransparent, ... of colors, with an appearance similar to stained ...
Cached Biology Technology:Laureate Pharma Announces Manufacturing Agreement With Alopexx Pharmaceuticals, LLC 2Laureate Pharma Announces Manufacturing Agreement With Alopexx Pharmaceuticals, LLC 3Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales 2Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales 3Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales 4Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales 5Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales 6Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales 7Carbon nanotubes made into conductive, flexible 'stained glass' 2
Human beta IG-H3 MAb (Clone 348506) Keywords: BIGH3, betaIG-H3 Protein Family: Extracellular Matrix Molecules...
Rat CNTF R alpha Affinity Purified Polyclonal Ab...
TUNEL Apoptosis Detection Kit...
homeo box D3, mRNA...
Biology Products: